NFA
ALDR

Nationwide Fund Advisors’s Alder Biopharmaceuticals ALDR Stock Holding History

Nationwide Fund Advisors’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-32,480
Closed -$398K – 2767
2017
Q3 		$398K Sell
32,480
-25,657
-44% -$268K ﹤0.01% 2294
2017
Q2 		$666K Buy
58,137
+11,853
+26% +$219K ﹤0.01% 2025
2017
Q1 		$963K Sell
46,284
-1,937
-4% -$42.9K ﹤0.01% 1766
2016
Q4 		$1M Sell
48,221
-1,478
-3% -$38.4K ﹤0.01% 1782
2016
Q3 		$1.63M Hold
49,699
– – 0.01% 1492
2016
Q2 		$1.24M Buy
49,699
+16,126
+48% +$436K 0.01% 1604
2016
Q1 		$834K Buy
33,573
+3,193
+11% +$73.9K ﹤0.01% 1819
2015
Q4 		$1M Buy
30,380
+15,457
+104% +$523K ﹤0.01% 1734
2015
Q3 		$489K Buy
14,923
+1,584
+12% +$67.3K ﹤0.01% 2133
2015
Q2 		$707K Buy
13,339
+5,926
+80% +$216K ﹤0.01% 2052
2015
Q1 		$214K Buy
7,413
+1,204
+19% +$33K ﹤0.01% 2657
2014
Q4 		$181K Hold
6,209
– – ﹤0.01% 2682
2014
Q3 		$79K Buy
6,209
+130
+2% +$1.97K ﹤0.01% 3044
2014
Q2 		$122K Buy
+6,079
New +$85.6K ﹤0.01% 2963

Other funds holding ALDR

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Nationwide Fund Advisors's ALDR Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Alder Biopharmaceuticals (ALDR) in Q4 2017, closing a stake of 32,480 shares — an estimated $398K sold.

Nationwide Fund Advisors first reported a position in ALDR in Q2 2014 and held it in 14 quarters. The position peaked at $1.63M in Q3 2016. 140 funds tracked by Wall St. Rank hold ALDR as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Alder Biopharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 32,480 Alder Biopharmaceuticals shares in Q4 2017, an estimated $398K.
  • Nationwide Fund Advisors first reported a position in Alder Biopharmaceuticals in Q2 2014 and held it in 14 quarters.
  • Nationwide Fund Advisors's Alder Biopharmaceuticals position peaked at $1.63M in Q3 2016.
  • 140 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.